In short
Veracor partners with existing provider organizations rather than building a parallel delivery system. Each arrangement starts as a pilot in a small number of facilities with agreed success criteria, protocols are integrated into existing clinician workflows, the health system remains custodian of patient data, and commercial terms expand only as pilot results justify it.
Key takeaways
- Pilot first: a defined patient population, a few facilities, agreed success criteria.
- Protocols go inside existing clinician workflows rather than on top of them.
- The health system stays custodian of patient data.
- Veracor is in discussion with regional providers; no partner is named and no agreement is final.
Signal-based medicine works best inside networks that already have patients, clinicians and referral pathways. Rather than building a parallel delivery system, Veracor is pursuing partnerships that place its monitoring and proactive-care protocols inside established provider organizations, with the Southeast United States as the initial focus.
Why partner instead of building a provider network?
Because the expensive parts already exist. A provider organization has licensed clinicians, patient relationships, referral patterns, credentialing, malpractice coverage and payer contracts. Recreating that to deliver a monitoring protocol would take years and would compete with the organizations best positioned to adopt the protocol. Partnering puts the capability where the patients are.
How are these arrangements structured?
Deliberately narrow at the start:
- Pilot first. A defined patient population in a small number of facilities, with success criteria agreed in writing before any expansion is discussed.
- Clinician-led. Protocols are integrated into existing workflows rather than layered on top of them. If a clinician has to open a second application, the protocol will not be used consistently.
- Data held by the provider. The health system remains custodian of patient data, with access governed by the partnership agreement and applicable privacy law.
- Staged commercial terms. Scope and economics expand only as pilot results justify it.
- Defined exit. Both sides know in advance what ending the pilot looks like, including data handling on termination.
What does a pilot actually test?
Three things, in order. Whether the monitoring produces a signal clinicians consider actionable. Whether the alert reaches the right person inside their existing workflow and is acted on. Whether the resulting intervention changes anything measurable for the patient population. A pilot that only proves the technology functions has not tested the part that matters.
What is the expected sequence?
Where a partnership proceeds: a pilot phase, then an expansion phase informed by what the pilot showed, then broader network integration only after both. Timelines depend on the partner's own clinical governance, security review and contracting process, which commonly run six to twelve months before a pilot starts. Veracor plans for that rather than treating it as a delay.
How is patient data protected?
The provider organization remains the custodian of the record. Access by Veracor or a portfolio company is limited to what the agreement specifies for the pilot's stated purpose, under applicable privacy law and the partner's own security requirements. Security posture is treated as a gating item in these discussions, not a later cleanup task.
What is the current status?
Veracor is in discussion with regional provider organizations about arrangements of this type. No partner is being named, and no agreement should be assumed final until the firm announces it specifically. Discussions can end without a transaction.
What makes a pilot fail?
Rarely the technology. The recurring causes are a success criterion nobody agreed on in writing, an alert routed to a role with no authority to act, a clinical champion who leaves mid-pilot, and no identified budget owner for the expansion that was supposed to follow. Veracor tries to surface all four before a pilot starts, because each one is cheap to fix in a contract and expensive to fix in month five.
What does the provider organization get out of it?
Capability it would otherwise have to build: continuous visibility into a population between visits, a ranked view of which patients need clinical time this week, and the reporting infrastructure that risk-bearing contracts require. For a system already carrying outcome risk, those are direct financial interests rather than goodwill.
How long does a partnership take to reach scale?
Longer than most technology timelines assume. Clinical governance review, security assessment and contracting commonly run six to twelve months before a pilot begins, the pilot itself needs enough time for a measurable clinical signal, and expansion follows the partner's own budget cycle. A realistic path from first conversation to network-wide integration is measured in years. Veracor capitalizes for that rather than treating it as an obstacle to route around.
How can a provider organization start a conversation?
Through the contact form on this site. The most productive first conversations involve a specific patient population the organization already worries about, such as a group with high readmission rates or a panel too large for its available clinical time.
Important note
This article describes an intended partnership approach and is not medical, investment, legal or tax advice. Forward-looking statements about pilots, timelines and expansion are subject to change, and no agreement or outcome is promised.
744 words. Published October 15, 2024.
